{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:54:00Z","timestamp":1793922840763,"version":"4.8.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharm Bioall Sci"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/jpbs.jpbs_239_19","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T08:36:50Z","timestamp":1595234210000},"page":"295","source":"Crossref","is-referenced-by-count":35,"title":["Standardization of type 1 and type 2 diabetic nephropathy models in rats: Assessment and characterization of metabolic features and renal injury"],"prefix":"10.4103","volume":"12","author":[{"given":"Sadhana","family":"Sathaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AakrutiA","family":"Kaikini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Dhodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suraj","family":"Muke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhavi","family":"Peshattiwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Bagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruna","family":"Korde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayula","family":"Sarnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Kadwad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satbir","family":"Sachdev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0975-7406.290120-1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045","author":"Cho","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"key-10.4103\/0975-7406.290120-2","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc10-S062","article-title":"Diagnosis and classification of diabetes mellitus","author":"American","year":"2010","journal-title":"Diabetes Care"},{"key":"key-10.4103\/0975-7406.290120-3","first-page":"6","article-title":"Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management","author":"Chaudhury","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"key-10.4103\/0975-7406.290120-4","doi-asserted-by":"crossref","unstructured":"Pickering RJ, Rosado CJ, Sharma A, Buksh S, Tate M, de Haan JB Recent novel approaches to limit oxidative stress and inflammation in diabetic complications. Clin Transl Immunol 2018;7:e1016.","DOI":"10.1002\/cti2.1016"},{"key":"key-10.4103\/0975-7406.290120-5","doi-asserted-by":"crossref","unstructured":"Hefti FF Requirements for a lead compound to become a clinical candidate. BMC Neurosci 2008;9:S7.","DOI":"10.1186\/1471-2202-9-S3-S7"},{"key":"key-10.4103\/0975-7406.290120-6","first-page":"9051426","article-title":"Experimental diabetes mellitus in different animal models","author":"Al-Awar","year":"2016","journal-title":"J Diabetes Res"},{"key":"key-10.4103\/0975-7406.290120-7","doi-asserted-by":"crossref","unstructured":"Wu J, Yan LJ Streptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic \u03b2 cell glucotoxicity. Diabetes Metab Syndr Obes 2015;8:181-8.","DOI":"10.2147\/DMSO.S82272"},{"key":"key-10.4103\/0975-7406.290120-8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2337\/diab.47.2.224","article-title":"Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide","author":"Masiello","year":"1998","journal-title":"Diabetes"},{"key":"key-10.4103\/0975-7406.290120-9","doi-asserted-by":"crossref","first-page":"e13395","DOI":"10.1111\/jfpp.13395","article-title":") seed flour on the chemical characteristics, biological activities, and sensory profile of fortified bread","author":"Chaubey","year":"2018","journal-title":"J Food Process Preserv"},{"key":"key-10.4103\/0975-7406.290120-10","doi-asserted-by":"crossref","unstructured":"Cacho J, Sevillano J, de Castro J, Herrera E, Ramos MP Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats. Am J Physiol Endocrinol Metab 2008;295:E1269-76.","DOI":"10.1152\/ajpendo.90207.2008"},{"key":"key-10.4103\/0975-7406.290120-11","doi-asserted-by":"crossref","unstructured":"Nayak Y, Hillemane V, Daroji VK, Jayashree BS, Unnikrishnan MK Antidiabetic activity of benzopyrone analogues in nicotinamide-streptozotocin induced type 2 diabetes in rats. Scientificworldjournal 2014;2014:854267.","DOI":"10.1155\/2014\/854267"},{"key":"key-10.4103\/0975-7406.290120-12","doi-asserted-by":"crossref","unstructured":"Kanchan DM, Somani GS, Peshattiwar VV, Kaikini AA, Sathaye S Renoprotective effect of diosgenin in streptozotocin induced diabetic rats. Pharmacol Rep 2016;68:370-7.","DOI":"10.1016\/j.pharep.2015.10.011"},{"key":"key-10.4103\/0975-7406.290120-13","doi-asserted-by":"crossref","unstructured":"Kishore L, Kaur N, Singh R Nephroprotective effect of Paeonia emodi via inhibition of advanced glycation end products and oxidative stress in streptozotocin-nicotinamide induced diabetic nephropathy. J Food Drug Anal 2017;25:576-88.","DOI":"10.1016\/j.jfda.2016.08.009"},{"key":"key-10.4103\/0975-7406.290120-14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1258\/ebm.2012.011372","article-title":"Characteristics of the experimental model","author":"Szkudelski","year":"2012","journal-title":"Exp Biol Med (Maywood)"},{"key":"key-10.4103\/0975-7406.290120-15","doi-asserted-by":"crossref","unstructured":"Wu KK, Huan Y Streptozotocin-induced diabetic models in mice and rats. Curr Protoc Pharmacol 2008;Chapter 5:Unit 5.47.","DOI":"10.1002\/0471141755.ph0547s40"},{"key":"key-10.4103\/0975-7406.290120-16","doi-asserted-by":"crossref","unstructured":"Ghasemi A, Khalifi S, Jedi S Streptozotocin-nicotinamide-induced rat model of type 2 diabetes (review). Acta Physiol Hung 2014;101:408-20.","DOI":"10.1556\/APhysiol.101.2014.4.2"},{"key":"key-10.4103\/0975-7406.290120-17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1242\/dmm.006239","article-title":"Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice","author":"Ayala","year":"2010","journal-title":"Dis Model Mech"},{"key":"key-10.4103\/0975-7406.290120-18","doi-asserted-by":"crossref","unstructured":"Furman BL Streptozotocin-induced diabetic models in mice and rats. Curr Protoc Pharmacol 2015;70:5.47.1-5.47.20.","DOI":"10.1002\/0471141755.ph0547s70"},{"key":"key-10.4103\/0975-7406.290120-19","unstructured":"Adinortey M Biochemicophysiological mechanisms underlying signs and symptoms associated with diabetes mellitus. Adv Biol Res 2017;11:382-90."},{"key":"key-10.4103\/0975-7406.290120-20","doi-asserted-by":"crossref","unstructured":"Anand BK, Chhina GS, Singh B Effect of glucose on the activity of hypothalamic \u201cfeeding centers\u201d. Science 1962;138:597-8.","DOI":"10.1126\/science.138.3540.597"},{"key":"key-10.4103\/0975-7406.290120-21","doi-asserted-by":"crossref","unstructured":"Boden G, Laakso M Lipids and glucose in type 2 diabetes: what is the cause and effect? Diabetes Care 2004;27:2253-9.","DOI":"10.2337\/diacare.27.9.2253"},{"key":"key-10.4103\/0975-7406.290120-22","doi-asserted-by":"crossref","unstructured":"Goldberg IJ Clinical review 124: diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab 2001;86:965-71.","DOI":"10.1210\/jcem.86.3.7304"},{"key":"key-10.4103\/0975-7406.290120-23","doi-asserted-by":"crossref","unstructured":"Verg\u00e8s B Pathophysiology of diabetic dyslipidaemia: where are we? Diabetologia 2015;58:886-99.","DOI":"10.1007\/s00125-015-3525-8"},{"key":"key-10.4103\/0975-7406.290120-24","doi-asserted-by":"crossref","unstructured":"Howard BV Lipoprotein metabolism in diabetes mellitus. J Lipid Res 1987;28:613-28.","DOI":"10.1016\/S0022-2275(20)38659-4"},{"key":"key-10.4103\/0975-7406.290120-25","unstructured":"Koletsky P The glucose tolerance test as a laboratory tool with clinical implications. IntechOpen 2012. DOI: 105772\/54785 Available from: https:\/\/wwwintechopencom\/books\/glucose-tolerance\/the-glucose-tolerance-test-as-a-laboratory-tool-with-clinical-implications [Last accessed on 17th September 2019]."},{"key":"key-10.4103\/0975-7406.290120-26","doi-asserted-by":"crossref","unstructured":"Akinmokun A, Selby PL, Ramaiya K, Alberti KG The short insulin tolerance test for determination of insulin sensitivity: a comparison with the euglycaemic clamp. Diabet Med 1992;9:432-7.","DOI":"10.1111\/j.1464-5491.1992.tb01813.x"},{"key":"key-10.4103\/0975-7406.290120-27","doi-asserted-by":"crossref","unstructured":"Patarr\u00e3o RS, Wayne Lautt W, Paula Macedo M Assessment of methods and indexes of insulin sensitivity. Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo 2014;9:65-73.","DOI":"10.1016\/j.rpedm.2013.10.004"},{"key":"key-10.4103\/0975-7406.290120-28","doi-asserted-by":"crossref","unstructured":"Wallace TM, Levy JC, Matthews DR Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-95.","DOI":"10.2337\/diacare.27.6.1487"},{"key":"key-10.4103\/0975-7406.290120-29","doi-asserted-by":"crossref","unstructured":"Chen H, Sullivan G, Quon MJ Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model. Diabetes 2005;54:1914-25.","DOI":"10.2337\/diabetes.54.7.1914"},{"key":"key-10.4103\/0975-7406.290120-30","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans","author":"Katz","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0975-7406.290120-31","doi-asserted-by":"crossref","unstructured":"Dabla PK Renal function in diabetic nephropathy. World J Diabetes 2010;1:48-56.","DOI":"10.4239\/wjd.v1.i2.48"},{"key":"key-10.4103\/0975-7406.290120-32","doi-asserted-by":"crossref","unstructured":"Brownlee M The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005;54:1615-25.","DOI":"10.2337\/diabetes.54.6.1615"},{"key":"key-10.4103\/0975-7406.290120-33","doi-asserted-by":"crossref","unstructured":"Fakhruddin S, Alanazi W, Jackson KE Diabetes-induced reactive oxygen species: mechanism of their generation and role in renal injury. J Diabetes Res 2017;2017: 8379327.","DOI":"10.1155\/2017\/8379327"},{"key":"key-10.4103\/0975-7406.290120-34","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1681\/ASN.2010010010","article-title":"Pathologic classification of diabetic nephropathy","author":"Tervaert","year":"2010","journal-title":"J Am Soc Nephrol"}],"container-title":["Journal of Pharmacy And Bioallied Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:47:16Z","timestamp":1786733236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jpbs.JPBS_239_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"alternative-id":["290120"],"URL":"https:\/\/doi.org\/10.4103\/jpbs.jpbs_239_19","relation":{},"ISSN":["0975-7406"],"issn-type":[{"value":"0975-7406","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}